EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An OGT Missense Variant With Impaired Enzyme Activity in a Child With Severe Developmental Delay and Hepatoblastoma

Alfonso Manuel D'Alessio iD, Huijie Yuan iD, Leandro Raul Soria, Sara Basse Hansen iD, Iolanda Boffa, Paola Arena, Benedetta Attianese, Maureen O'Sullivan, Noelle Cullinan, Lewis Pang, Daan Marinus Ferdinand van Aalten, Nicola Brunetti-Pierri iD und 1 weitere

American Journal of Medical Genetics Part A · 2026

DOI: 10.1002/ajmg.a.64275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Alfonso Manuel D'Alessio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Developmental Disabilities, Hepatoblastoma, Liver Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Villum Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O‐GlcNAc transferase (OGT) and its antagonist O‐GlcNAcase (OGA) regulate protein O‐GlcNAcylation, a highly conserved post‐translational modification involved in metabolic sensing. Pathogenic variants in the OGT gene cause an X‐linked congenital disorder of glycosylation (OGT‐CDG) presenting developmental delay, hypotonia, intellectual disability, and dysmorphic features. Here, we report on a child with developmental delay, hypotonia, and dysmorphic features who was found to carry a hemizygous novel OGT variant. This child also developed hepatoblastoma by the age of 17 months. OGT‐CDG was diagnosed by exome sequencing that identified a de novo missense variant in the OGT gene. Functional validation by Western blot on patient‐derived fibroblasts showed reduced O‐GlcNAcylation and OGA expression, while significantly reduced enzyme activity in vitro confirmed the pathogenicity of the variant. To date, no patients with OGT‐CDGs have been reported with hepatoblastoma or other malignancies. Although the occurrence of hepatoblastoma in the proband might be coincidental, the role of O‐GlcNAcylation in cancer suggests that the deficiency of OGT activity might be associated with increased cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationDevelopmental DisabilitiesHepatoblastomaLiver NeoplasmsMutation, MissenseN-AcetylglucosaminyltransferasesHumansInfantExome SequencingGlycosylation

Stichwörter der Autor:innen

OGT variantOGT‐CDGO‐GlcNAc transferasecongenital disorder of glycosylationhepatoblastomaintellectual disabilityrare disease

Substanzen

N-AcetylglucosaminyltransferasesOGT protein, human

Autor:innen und Institutionen

  • Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Scuola Superiore Meridionale, Genomics and Experimental Medicine Program, Federico II University, Naples, Italy.
  • Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
  • Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.
  • Histology Laboratory, Children's Health Ireland, Dublin, Ireland.

ORCID-Profile: Alfonso Manuel D'Alessio, Huijie Yuan, Sara Basse Hansen, Nicola Brunetti-Pierri

Förderung

  • Novo Nordisk Fonden
  • Villum Fonden

Zitieren

APA

D'Alessio, A. M., Yuan, H., Soria, L. R., Hansen, S. B., Boffa, I., Arena, P., Attianese, B., O'Sullivan, M., Cullinan, N., Pang, L., van Aalten, D. M. F., Brunetti-Pierri, N., & Lynch, S. A. (2026). An OGT Missense Variant With Impaired Enzyme Activity in a Child With Severe Developmental Delay and Hepatoblastoma. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64275

Vancouver

D'Alessio AM, Yuan H, Soria LR, Hansen SB, Boffa I, Arena P, et al. An OGT Missense Variant With Impaired Enzyme Activity in a Child With Severe Developmental Delay and Hepatoblastoma. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64275

BibTeX
@article{DAlessio2026,
  author = {D'Alessio, Alfonso Manuel and Yuan, Huijie and Soria, Leandro Raul and Hansen, Sara Basse and Boffa, Iolanda and Arena, Paola and Attianese, Benedetta and O'Sullivan, Maureen and Cullinan, Noelle and Pang, Lewis and van Aalten, Daan Marinus Ferdinand and Brunetti-Pierri, Nicola and Lynch, Sally Ann},
  title = {An OGT Missense Variant With Impaired Enzyme Activity in a Child With Severe Developmental Delay and Hepatoblastoma},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmg.a.64275}
}
Kostenlos starten →